Biotech / Medical: ArQule, Inc. (ARQL)
Posts: 538 | Member SubjectMarks: 51 | No Bans

Add SubjectMark | Hide Original Post | Show Chart | Poster Summary | Share This Board

Moderated By: tuck -- (Not Moderated) -- Started: 4/4/2003 12:52:55 AM  Revision History

I was surprised to find that there is no thread for ArQule. Perhaps there was once, and it died. Not unlike the stock price. My curiosity got piqued when I found that BVF had recently acquired an 11% stake. Lately Pfizer has taken one of similar size pursuant to a milestone. Currently, ARQL trades for way less than cash, and I know nothing about it.

Any help appreciated.
Previous 10 | Next 10 | View Recent | Post Message Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsDate
538>>Daiichi Sankyo Company, Limited (TSE 4568) and ArQule, Inc. (ARQL) todatuck-01/31/2013 08:32 PM
537>Shouldn't the burn rate decline with the completion of the trial -- or dpgo-neil-10/02/2012 03:29 PM
536Shouldn't the burn rate decline with the completion of the trial -- or did ymopgcw-10/02/2012 12:49 PM
535Bad news for ARQL's flagship drug, Tiva... l think their burn rate is aboupgo-neil-10/02/2012 09:22 AM
534Letter to Shareholders(4/24/12) LETTER TO STOCKHOLDERS We completed a transArthur Radley-04/25/2012 10:34 PM
533Hi Doc! I was madly shooting at shares just after the news came out, but then scaram(o)uche-04/11/2012 11:16 AM
532Funny! Yesterday when they announced the deal they mentioned Citi and Leerink asArthur Radley-04/11/2012 10:47 AM
531Priced at $7.30. How much is timing, announcing this during one of the bigger otuck-04/11/2012 10:08 AM
530Location! Location--in buying real estate! Timing! Timing--in buying biotechs. LArthur Radley-04/10/2012 02:37 PM
529NIce of them to wait until the price got back to levels at which they previouslytuck-04/10/2012 12:16 PM
528what did you do here rick:-) I wished they waited for 6m... WOBURN, Mass.--(BUSdr.praveen-04/10/2012 10:01 AM
Previous 10 | Next 10 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
Copyright © 1995-2013 Knight Sac Media. All rights reserved.